R. Ma

发表

Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study

Yan Li, Xin-Bao Li, Yu-Lin Lin, 2021, Diagnostic Pathology.

Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study

Yan Li, Xin-Bao Li, Yu-Lin Lin, 2021, Diagnostic Pathology.

Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer

Yan Li, Yongshun Chen, Jiamei Chen, 2021, Diagnostics.

NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine

Yangfan Su, Yan Li, R. Ma, 2022, World Journal of Surgical Oncology.

Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases.

Yan Li, Gang Liu, R. Ma, 2021, Annals of translational medicine.

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients

Yan Li, Jue Zhang, Xin-Bao Li, 2021, BioMed research international.

Clinical epidemiology of peritoneal metastases in China: The construction of professional peritoneal metastases treatment centers based on the prevalence rate.

R. Ma, R. Yang, Yanhong Su, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases

Yangfan Su, Yan Li, R. Ma, 2022, World Journal of Surgical Oncology.

Further predictive value of lymphovascular invasion explored via supervised deep learning for lymph node metastases in breast cancer.

Yaofeng Wen, Dahong Qian, Yongshun Chen, 2022, Human pathology.

Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma

Z. Li, Qian Chen, Yan Li, 2020, Experimental animals.

The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review

Yan Li, R. Ma, Yulin Lin, 2020, Journal of Cancer Research and Clinical Oncology.

Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study

Yanping Su, R. Ma, Zhi-ran Yang, 2022, Frontiers in Oncology.

Establishment of patient‐derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5‐fluorouracil

Qian Chen, Yan Li, Jue Zhang, 2019, Cancer medicine.

Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer

Yan Li, Jue Zhang, Z. Ji, 2021, Translational cancer research.

The clinical significance of serum SCC-Ag combined with CD 105 in patients with cervical cancer during the early stage diagnosis

R. Ma, H. Bi, Sen-Yang Cao, 2016 .

Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.

Yan Li, Jue Zhang, Z. Ji, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Ying Zhang, Yan Li, R. Ma, 2022, Cancer medicine.

Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study.

Yangfan Su, Yan Li, Xin Zhao, 2023, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome

Yangfan Su, R. Ma, Xinbao Li, 2024, World journal of surgical oncology.

Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.

R. Ma, Zhi-ran Yang, Xin-li Liang, 2024, Journal of surgical oncology.

Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei

R. Ma, Yu-Bin Fu, Yandong Su, 2024, Cancer biology & medicine.

Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Yangfan Su, Yan Li, Yang Yu, 2023, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.